Known targets — ChEMBL curated mechanism
ABCC8ACEADORA1ADORA2AADORA2BADORA3ALDH5A1ALOX5ALOX5APATP4AATP4BBRAFCA1CA12CA2CA4CYSLTR1DHFRDPEP1EDNRAEDNRBESR2F10FDPSFGF1GABBR1GABBR2GABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGARTGNRHRGSC1HMGCRIMPDH1IMPDH2KCNJ11LY96NOD2NR3C1NS3NS4ANS5bP2RY1P2RY12P2RY2P2RY4P2RY6PBP2XPDE3APDE3BPDE4APDE4BPDE4CPDE4DPDK1PDK2PDK3PDK4PPARGPPATPTGIRPTGS1PTGS2RAF1RYR1RYR3SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASERPINC1SLC12A1SLC12A3SYKTHRATHRBTLR3TLR4TLR9TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8TYMSVKORC1XDHblablaIMP-1blaOXA-33blaOXA-58blaT-3blaT-4blaT-5blaT-6dacAdacBdacCfolAfolPfolP1ftsIfusAgaggyrAgyrBmecAmrcAmrcBmrdApbp1apbp1bpbp2pbp2apbp2bpbp3pbp4pbpApbpBpbpCpbpFpolponBrplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpoArpoBrpoCrpoZrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of None. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FDPS known ✓ | P14324 | 2/20 | 0.41 |
| ▸ | CA1 known ✓ | P00915 | 1/20 | 0.39 |
| ▸ | SMPD1 | P17405 | 4/20 | 0.41 |
| ▸ | FABP3 | P05413 | 5/20 | 0.40 |
| ▸ | GPR84 | Q9NQS5 | 1/20 | 0.38 |
| ▸ | CES2 | O00748 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28807752 | 0.84 | PLA2G2A (0.44) | SMPD1FDPSFABP3GPR84 | |
| SCHEMBL1446187 | 0.84 | PLA2G2A (0.44) | SMPD1FDPSFABP3GPR84 | |
| SCHEMBL28298177 | 0.84 | PLA2G2A (0.44) | SMPD1FDPSFABP3GPR84 | |
| Hydrochloric Acid SCHEMBL28264679 | 0.82 | PLA2G2A (0.43) | SMPD1FDPSFABP3GPR84 | |
| SCHEMBL1115354 | 0.82 | PLA2G2A (0.43) | SMPD1FDPSFABP3GPR84 | |
| Hydrochloric Acid SCHEMBL1115261 | 0.82 | PLA2G2A (0.43) | SMPD1FDPSFABP3GPR84 | |
| Hydrochloric Acid SCHEMBL5073983 | 0.82 | PLA2G2A (0.43) | SMPD1FDPSFABP3GPR84 | |
| Acetic Acid SCHEMBL27859692 | 0.76 | SMPD1 (0.47) | SMPD1FDPSCA1CES2 | |
| SCHEMBL29827178 | 0.74 | SMPD1 (0.46) | SMPD1FDPSCA1CES2 | |
| SCHEMBL31457837 | 0.74 | SMPD1 (0.46) | SMPD1FDPSCA1CES2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 35 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3443951-B1 | SUPERFATTING AGENT AND PERSONAL CARE COMPOSITION | SABO SPA (IT) | 2022-09-21 | — | — | EP | disclosed |
| EP-3443951-A1 | SUPERFATTING AGENT AND PERSONAL CARE COMPOSITION | Sabo S.p.A. (IT) | 2019-02-20 | — | — | EP | disclosed |
| US-8920927-B2 | Resin particle and resin dispersion | SANYO CHEMICAL INDUSTRIES, LTD (JP) | 2014-12-30 | — | — | US | disclosed |
| US-8852741-B2 | Resin particle and resin dispersion | SANYO CHEMICAL INDUSTRIES, LTD. (JP) | 2014-10-07 | — | — | US | disclosed |
| US-8278350-B2 | Agent for skin external use containing salt of ascorbic acid derivative, method for stabilizing the agent for skin external use, and stabilizer | SHOWA DENKO K.K. (JP) | 2012-10-02 | — | — | US | disclosed |
| US-8242169-B2 | Emulsion composition | SHOWA DENKO K.K. (JP) | 2012-08-14 | — | — | US | disclosed |
| US-20110269874-A1 | RESIN PARTICLE AND RESIN DISPERSION | SANYO CHEMICAL INDUSTRIES, LTD. (JP) | 2011-11-03 | — | — | US | disclosed |
| EP-1887027-B1 | RESIN PARTICLE AND RESIN DISPERSION | SANYO CHEMICAL IND LTD (JP) | 2011-06-08 | — | — | EP | disclosed |
| US-7862896-B2 | Core-shell resin particle having low content of volatile components, and resin dispersion | SANYO CHEMICAL INDUSTRIES, LTD. (JP) | 2011-01-04 | — | — | US | disclosed |
| US-20090264578-A1 | Aggregation-preventive aqueous dispersion slurry coating material and process for producing the same | SANYO CHEMICAL INDUSTRIES, LTD. (JP) | 2009-10-22 | — | — | US | disclosed |
| EP-1710272-A1 | RESIN DISPERSION AND RESIN PARTICLE | SANYO CHEMICAL INDUSTRIES, LTD. (JP) | 2006-10-11 | — | — | EP | disclosed |
| US-20060222616-A1 | Cosmetic composition comprising a and a lipopeptide | KANEKA CORPORATION (JP) | 2006-10-05 | — | — | US | disclosed |
| EP-1689494-A1 | AGENT FOR SKIN EXTERNAL USE CONTAINING SALT OF ASCORBIC ACID DERIVATIVE, METHOD FOR STABILIZING THE AGENT FOR SKIN EXTERNAL USE, AND STABILIZER | Showa Denko K.K. (JP) | 2006-08-16 | — | — | EP | disclosed |
| EP-1660025-A1 | COSMETIC COMPOSITION CONTAINING A POLYOXYETHYL COMBINATION AND A LIPOPEPTIDE | Showa Denko K.K. (JP) | 2006-05-31 | — | — | EP | disclosed |
| WO-2005094777-A1 | EXTERNAL PREPARATION FOR SKIN | SHOWA DENKO K.K. (JP) | 2005-10-13 | — | — | WO | disclosed |
| WO-2005095462-A1 | MOISTURE RETENTION POLYMER COMPOUND | SHOWA DENKO K.K. (JP) | 2005-10-13 | — | — | WO | disclosed |
| US-20050220744-A1 | Polysaccharide/functional compound complex | SHOWA DENKO K.K. | 2005-10-06 | — | — | US | disclosed |
| WO-2005089708-A1 | OIL-IN-WATER EMULSIFIED COMPOSITION, AND EXTERNAL PREPARATION FOR SKIN AND COSMETICS USING THE COMPOSITION | SHOWA DENKO K.K. (JP) | 2005-09-29 | — | — | WO | disclosed |
| WO-2005034903-A1 | AGENT FOR SKIN EXTERNAL USE CONTAINING SALT OF ASCORBIC ACID DERIVATIVE, METHOD FOR STABILIZING THE AGENT FOR SKIN EXTERNAL USE, AND STABILIZER | SHOWA DENKO K.K. (JP) | 2005-04-21 | — | — | WO | disclosed |
| WO-2005020950-A1 | COSMETIC COMPOSITION COMPRISING A AND A LIPOPEPTIDE | SHOWA DENKO K.K. (JP) | 2005-03-10 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060222616-A1 | Cosmetic composition comprising a and a lipopeptide | CUTA, SMURF1, FABP4 | FDPS 3983/4885CA1 4571/4885SMPD1 68/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.